1-Acryloyloxy-3-adamantanol
Product Information
Molecular Formula
C14H20O3
Molecular Weight
222.28
Description
1-Acryloyloxy-3-adamantanol is a useful reagent in the production of polymers and, due to its adamantane core, has potential applications in drug delivery systems. It could support research into treatments for a variety of diseases, including cancer and infectious diseases.
Synonyms
1-Acryloyloxy-3-adamantanol; 1,3-Adamantanediol monoacrylate
IUPAC Name
(3-hydroxy-1-adamantyl) prop-2-enoate
SMILES
C=CC(=O)OC12CC3CC(C1)CC(C3)(C2)O
InChI
InChI=1S/C13H18O3/c1-2-11(14)16-13-6-9-3-10(7-13)5-12(15,4-9)8-13/h2,9-10,15H,1,3-8H2
InChI Key
DKDKCSYKDZNMMA-UHFFFAOYSA-N
Boiling Point
314°C
Melting Point
70.0 to 74.0 °C
Flash Point
128 °C
Purity
99%
Density
1.2
Appearance
White to Almost white powder to crystal
Safety Information
Hazards
H315:
Causes skin irritation.
H319:
Causes serious eye irritation.
Causes skin irritation.
H319:
Causes serious eye irritation.
Precautionary Statement
P264:
Wash thoroughly after handling.
P280:
Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352:
IF ON SKIN:
Wash with plenty of soap and water.
P332+P313:
If skin irritation occurs:
Get medical advice/attention.
P337+P313:
If eye irritation persists:
Get medical advice/attention.
P362+P364:
Take off contaminated clothing. [As modified by IV ATP].
And wash it before reuse. [Added by IV ATP].
Wash thoroughly after handling.
P280:
Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352:
IF ON SKIN:
Wash with plenty of soap and water.
P332+P313:
If skin irritation occurs:
Get medical advice/attention.
P337+P313:
If eye irritation persists:
Get medical advice/attention.
P362+P364:
Take off contaminated clothing. [As modified by IV ATP].
And wash it before reuse. [Added by IV ATP].
Computed Properties
XLogP3
2
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
3
Exact Mass
222.125594432 g/mol
Monoisotopic Mass
222.125594432 g/mol
Topological Polar Surface Area
46.5Ų
Heavy Atom Count
16
Formal Charge
0
Complexity
333
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
2
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114058198-A | Composition for packaging OLED, packaging film layer and OLED display | 2022-01-07 |
| CN-114133483-A | Acrylate film forming resin containing adamantane structure, photoresist and preparation method | 2021-12-16 |
| JP-2021161378-A | Fluorine-based resins, compositions, photocrosslinked products, and electronic devices equipped with them. | 2020-03-31 |
| US-2021181633-A1 | Resist composition and method of forming resist pattern | 2019-12-11 |
| US-2021181634-A1 | Resist composition and method of forming resist pattern | 2019-12-11 |
| JP-2021082584-A | Conductive carbon material dispersant for lithium-ion batteries, slurry for lithium-ion battery electrodes, electrodes for lithium-ion batteries, and lithium-ion batteries | 2019-11-15 |
| JP-2021050298-A | Resin composition | 2019-09-26 |
| WO-2021028297-A1 | Low dielectric constant siliceous film manufacturing composition and methods for producing cured film and electronic device using the same | 2019-08-09 |
| CN-114207043-A | Composition for producing low dielectric constant siliceous film and method for producing cured film and electronic device using the same | 2019-08-09 |
| WO-2020246409-A1 | Fluororesin, active energy ray-curable composition, thermosetting composition, and cured products of compositions | 2019-06-06 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 17455959 | 2007-05-22 | Preparation of novel fluoroalkyl-end-capped 2-acrylamido-2-methylpropanesulfonic acid cooligomeric nanoparticles containing adamantane units possessing a lower critical solution temperature characteristic in organic media | Langmuir : the ACS journal of surfaces and colloids |
